Federal Court Hearing List

(As published on the Federal Court and Federal Court of Appeal websites on Mar 20, 2023 at 00:00:00)


This week in IP

DateFile No. Type Name LocationLength
Mar 20, 2023T-1168-21MDr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (PMNOC - Section 8 - Abiraterone*)Toronto3 h
Mar 20, 2023T-1838-22MAmgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto2 h
Mar 21, 2023T-1844-22JRTweak-d Inc. V. Attorney General Of Canada (Trade Mark - JR)Toronto3 h
Mar 21, 2023T-2627-22CMCJanssen Inc. V. The Minister Of Health & Agc (Patent)Toronto30 m
Mar 21, 2023T-481-23MIINLola Sheppard, Dba Lateral Office Et Al V. C S Design Inc. Et Al (Copyright)Montréal3 h
Mar 22, 2023T-1441-21TMCLeonard B French V. The Royal Canadian Legion (dominion Command) (Copyright)Vancouver1 h
Mar 22, 2023T-841-21CMCRovi Guides, Inc. V. Videotron Ltd. (Patent)Toronto1 h
Mar 23, 2023T-1831-22CMCBoehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*)Ottawa30 m
Mar 23, 2023T-1842-22CMCBoehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*)Ottawa30 m
Mar 23, 2023T-1331-22CMCAmanda Chen Et Al. V. Yan Tung Evelyn Chick Et Al. (Trade Mark)Ottawa1 h
Mar 24, 2023T-1004-22CMCGilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*)Toronto1 h
Mar 24, 2023T-1006-22CMCGilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*)Toronto1 h

Return to top.



Scheduled IP Trials

DateFile No.Name LocationLength
Apr 12, 2023T-1441-21Leonard B French V. The Royal Canadian Legion (dominion Command) (Copyright)Vancouver2 d
Apr 17, 2023T-609-20Wanakome Inc. V. Eric Martin Et Al. (Trade Mark)Montréal10 d
Apr 17, 2023T-127-19Fromfroid S.a. C. 1048547 Ontario Inc. Et Al. (Patent)Montréal5 d
May 8, 2023T-1924-17Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright)Toronto10 d
Jun 5, 2023T-1168-21Dr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (PMNOC - Section 8 - Abiraterone*)Toronto10 d
Jun 5, 2023T-1966-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)Montréal8 d
Jun 5, 2023T-379-21Molo Design, Ltd. V. Chanel Canada Ulc Et Al. (Patent)Montréal10 d
Jun 19, 2023T-607-21Apotex Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*)Toronto10 d
Jun 19, 2023T-1966-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)Montréal2 d
Jun 26, 2023T-17-16Ducks Lane Ltd. Et Al V. Outfront Media Llc Et Al (Trade Mark)Toronto5 d
Jul 10, 2023T-1472-21Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)Toronto15 d
Jul 10, 2023T-1475-21Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)Toronto15 d
Sep 11, 2023T-1962-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)Toronto5 d
Sep 11, 2023T-1994-21Allergan, Inc. Et Al. V. Juno Pharmaceuticals Corp. (Patent - Bimatoprost*)Toronto10 d
Sep 11, 2023T-1488-20Steelhead Lng (aslng) Ltd Et Al. V. Seven Gens Energy Ltd, Rockies Lng Et Al (Patent)Toronto10 d
Sep 18, 2023T-1686-18Wheel Monitor Inc. V. Cleral Inc. Et Al (Patent)Toronto7 d
Sep 21, 2023T-1962-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)Toronto2 d
Sep 25, 2023T-1869-21Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*)Toronto2 d
Oct 3, 2023T-1869-21Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*)Toronto4 d
Oct 3, 2023T-15-22Boehringer Ingleheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent - Linagliptin*)Toronto16 d
Oct 3, 2023T-343-20The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent)Toronto4 d
Oct 10, 2023T-1869-21Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*)Toronto4 d
Oct 10, 2023T-343-20The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent)Toronto4 d
Oct 16, 2023T-151-22Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*)Toronto10 d
Oct 16, 2023T-343-20The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent)Toronto2 d
Oct 23, 2023T-343-20The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent)Toronto1 d
Oct 30, 2023T-192-22Novartis Pharmaceuticals Canada Inc. Et Al. V. Teva Canada Limited (Patent - Sacubitril*)Ottawa10 d
Nov 9, 2023T-151-22Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*)To be determined (TrialJA)2 d
Nov 20, 2023T-919-21Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent)Toronto5 d
Nov 20, 2023T-1386-21Jcai Inc. V. Wiseleap Solutions Inc. Et Al (Patent)Ottawa12 d
Dec 1, 2023T-919-21Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent)Toronto1 d
Jan 8, 2024T-1004-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*)Toronto13 d
Jan 8, 2024T-1006-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*)Toronto13 d
Jan 29, 2024T-118-19Unilin Beheer B.v. Et Al V. Floors@work Inc. Et Al (Patent)Toronto13 d
Jan 29, 2024T-802-20Eis Inc. V. Wow Tech Canada Ltd. (Patent)Ottawa10 d
Feb 5, 2024T-1004-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*)Toronto2 d
Feb 5, 2024T-1006-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*)Toronto2 d
Feb 12, 2024T-997-22Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*)Toronto7 d
Feb 12, 2024T-953-17The Estate Of Vivian Maier V. Stephen M.bulger Et Al. (Copyright)Toronto2 d
Feb 15, 2024T-953-17The Estate Of Vivian Maier V. Stephen M.bulger Et Al. (Copyright)Toronto2 d
Feb 22, 2024T-118-19Unilin Beheer B.v. Et Al V. Floors@work Inc. Et Al (Patent)Toronto1.2 d
Feb 22, 2024T-953-17The Estate Of Vivian Maier V. Stephen M.bulger Et Al. (Copyright)Toronto2 d
Feb 29, 2024T-997-22Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*)Toronto2 d
Mar 4, 2024T-1241-22Bayer Inc. Et Al V. Bgp Pharma Ulc Et Al (Patent - Aflibercept*)Toronto10 d
Mar 4, 2024T-1484-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporation (Patent - Tenofovir*)Toronto10 d
Mar 4, 2024T-1607-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporaton (Patent - Tenofovir*)Toronto10 d
Mar 11, 2024T-1175-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent)Toronto13 d
Mar 11, 2024T-1176-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1178-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1181-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1187-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1188-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 18, 2024T-1121-22Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 18, 2024T-1122-22Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 18, 2024T-1248-22Janssen Inc. Et Al. V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 18, 2024T-1249-22Janssen Inc. Et Al. V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 25, 2024T-1484-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporation (Patent - Tenofovir*)Toronto2 d
Mar 25, 2024T-1607-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporaton (Patent - Tenofovir*)Toronto2 d
Apr 4, 2024T-1175-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent)Toronto2 d
Apr 4, 2024T-1176-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1178-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1181-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1187-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1188-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 8, 2024T-1555-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada), Inc. (Patent - Tenofovir*)Toronto9 d
Apr 8, 2024T-1556-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Tenofovir*)Toronto9 d
Apr 29, 2024T-1555-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada), Inc. (Patent - Tenofovir*)Toronto1 d
Apr 29, 2024T-1556-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Tenofovir*)Toronto1 d
Apr 29, 2024T-1174-21Bauer Hockey Ltd. V. Bladetech Hockey Inc. (Patent)Montréal10 d
Apr 29, 2024T-1769-21Bauer Hockey Ltd. V. Flare Skate Blade Ltd. (Patent)Montréal10 d
May 6, 2024T-1563-22Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*)Toronto10 d
May 7, 2024T-1750-22Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*)Toronto9 d
May 13, 2024T-2029-22Bayer Inc Et Al V. Bgp Pharma Ulc(viatris Canada) (Patent - Aflibercept*)Toronto5 d
May 24, 2024T-1750-22Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*)Toronto1 d
May 27, 2024T-1838-22Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto12 d
May 27, 2024T-1563-22Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*)Toronto2 d
May 27, 2024T-1831-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*)To be determined (TrialJA)20 d
May 27, 2024T-1842-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*)To be determined (TrialJA)20 d
Jun 14, 2024T-1838-22Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto6 d
Jun 17, 2024T-1449-20Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent)To be determined (TrialJA)10 d
Jun 24, 2024T-2251-22Bausch Health Ireland Ltd. Et Al V. Pharmascience Inc. (Patent - Efinaconazole*)To be determined (TrialJA)5 d
Jun 25, 2024T-1831-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*)To be determined (TrialJA)3 d
Jun 25, 2024T-1842-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*)To be determined (TrialJA)3 d
Jul 2, 2024T-1838-22Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto2 d
Jul 3, 2024T-1449-20Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent)To be determined (TrialJA)3 d
Jul 4, 2024T-2251-22Bausch Health Ireland Ltd. Et Al V. Pharmascience Inc. (Patent - Efinaconazole*)To be determined (TrialJA)2 d
Jul 15, 2024T-2276-22Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)To be determined (TrialJA)10 d
Jul 15, 2024T-2318-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)To be determined (TrialJA)10 d
Aug 12, 2024T-2276-22Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)To be determined (TrialJA)10 d
Aug 12, 2024T-2318-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)To be determined (TrialJA)10 d
Aug 12, 2024T-2133-22Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*)Toronto10 d
Aug 12, 2024T-2139-22Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*)Toronto10 d
Aug 26, 2024T-2279-22Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)To be determined (TrialJA)5 d
Aug 28, 2024T-2276-22Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)To be determined (TrialJA)3 d
Aug 28, 2024T-2318-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)To be determined (TrialJA)3 d
Aug 29, 2024T-2133-22Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*)Toronto2 d
Aug 29, 2024T-2139-22Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*)Toronto2 d
Sep 3, 2024T-2279-22Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)To be determined (TrialJA)4 d
Sep 9, 2024T-2178-22Boehringer Ingelheim (canada) Ltd V. Accord Healthcare Inc. (Patent - Nintedanib*)Toronto9 d
Sep 9, 2024T-2179-22Boehringer Ingelheim (canada) Ltd Et Al V. Accord Health Inc. (Patent - Nintedanib*)Toronto9 d
Sep 13, 2024T-2279-22Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)To be determined (TrialJA)1 d
Sep 27, 2024T-2178-22Boehringer Ingelheim (canada) Ltd V. Accord Healthcare Inc. (Patent - Nintedanib*)Toronto1 d
Sep 27, 2024T-2179-22Boehringer Ingelheim (canada) Ltd Et Al V. Accord Health Inc. (Patent - Nintedanib*)Toronto1 d
Oct 1, 2024T-192-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto9 d
Oct 1, 2024T-191-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent)Toronto9 d
Oct 1, 2024T-193-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto9 d
Oct 1, 2024T-194-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*)Toronto9 d
Oct 1, 2024T-195-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*)Toronto9 d
Oct 1, 2024T-196-23Boehringer Ingelheim (canada) Ltd. Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto9 d
Oct 1, 2024T-197-23Boehringer Ingelheim (canada)ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto9 d
Oct 21, 2024T-192-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto4 d
Oct 21, 2024T-191-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent)Toronto4 d
Oct 21, 2024T-193-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto4 d
Oct 21, 2024T-194-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*)Toronto4 d
Oct 21, 2024T-195-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*)Toronto4 d
Oct 21, 2024T-196-23Boehringer Ingelheim (canada) Ltd. Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto4 d
Oct 21, 2024T-197-23Boehringer Ingelheim (canada)ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto4 d
Oct 21, 2024T-269-23Novartis Pharmaceuticals Canada Inc. Et Al. V. Apotex Inc. (Patent - Nilotinib*)To be determined (TrialJA)8 d
Oct 21, 2024T-2307-22Astrazeneca Canada Inc. Et Al V. Pharmascience Inc. (Patent - Dapagliflozin*)To be determined (TrialJA)9 d
Oct 30, 2024T-192-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto2 d
Oct 30, 2024T-191-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent)Toronto2 d
Oct 30, 2024T-193-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto2 d
Oct 30, 2024T-194-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*)Toronto2 d
Oct 30, 2024T-195-23Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*)Toronto2 d
Oct 30, 2024T-196-23Boehringer Ingelheim (canada) Ltd. Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto2 d
Oct 30, 2024T-197-23Boehringer Ingelheim (canada)ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*)Toronto2 d
Nov 6, 2024T-269-23Novartis Pharmaceuticals Canada Inc. Et Al. V. Apotex Inc. (Patent - Nilotinib*)To be determined (TrialJA)2 d
Nov 8, 2024T-2307-22Astrazeneca Canada Inc. Et Al V. Pharmascience Inc. (Patent - Dapagliflozin*)To be determined (TrialJA)1 d
Nov 12, 2024T-1477-22Pfizer Canada Ulc And Pfizer Inc. V. Amgen Research (munich) Gmbh And Amgen (Patent - Elranatamab*)Toronto9 d
Nov 27, 2024T-1477-22Pfizer Canada Ulc And Pfizer Inc. V. Amgen Research (munich) Gmbh And Amgen (Patent - Elranatamab*)Toronto1 d
Nov 28, 2024T-1766-22Bayer Inc. Et Al V. Bgp Pharma Ulc D.b.a. Viatris Canada (Patent - Aflibercept*)Toronto10 d
Nov 28, 2024T-1482-22Bayer Inc. Et Al. V. Bgp Pharma Ulc D.b.a. Viatris Canada Et Al. (Patent - Aflibercept*)Toronto10 d
Dec 18, 2024T-1766-22Bayer Inc. Et Al V. Bgp Pharma Ulc D.b.a. Viatris Canada (Patent - Aflibercept*)Toronto2 d
Dec 18, 2024T-1482-22Bayer Inc. Et Al. V. Bgp Pharma Ulc D.b.a. Viatris Canada Et Al. (Patent - Aflibercept*)Toronto2 d

Return to top.



Scheduled Judicial Review Hearings

DateFile No.Name TypeLocationLength
Mar 21, 2023T-1844-22Tweak-d Inc. V. Attorney General Of CanadaTrade Mark - Appeal of a decision of the RegistrarToronto3 h
Mar 28, 2023T-1424-22Jeff Toth Et Al. V. Minister Of Health - Psilocybin*S. 18.1 Application for Judicial ReviewOttawa1 d
Apr 4, 2023T-1173-21Lazare V.t. Boubala, Lazare's Bbq House Inc. V. Mussa Siddiqui KhwajaCopyright Infringement [Applications]Ottawa3 h
Apr 13, 2023T-2081-22Les Industries Certico Inc. V. Mastrandrea Commercial Bakeries Ltd Et AlTrade Mark - Appeal of a decision of the RegistrarMontréal2 h
Apr 17, 2023T-1664-22Novartis Ag Et Al V. Biogen, Inc. Et AlTrade Mark InfringementToronto2 d
May 17, 2023T-1794-22Jean-louis Vill C. Bell CanadaTrade Mark - Appeal of a decision of the RegistrarMontréal1 d
May 25, 2023T-2627-22Janssen Inc. V. The Minister Of Health & AgcPatent - Appeal of a Decision of CommissionerToronto1 d
Jun 6, 2023T-1483-22Patagonia Inc V. Labatt Brewing Co. Ltd.Trade Mark ExpungementOttawa4 h
Jun 27, 2023T-2001-21Biologische Heilmittel Heel Gmbh V. Barrette Legal Inc.Trade Mark - Appeal of a decision of the RegistrarOttawa2 h
Nov 15, 2023T-1311-19Apotex Inc. V. Minister Of Health Et AlAccess to InformationToronto2 d
Jan 18, 2024T-132-22Apotex Inc. V. Minister Of Health Et Al.Access to InformationToronto1 d

Return to top.



Scheduled IP Appeals

DateFile No.Name TypeLocationLength
Mar 28, 2023A-129-22Voltage Holdings, Llc V. Doe #1 Et AlAppeal (S.27 - Interloc.) - Others [from T-513-18 - Copyright Infringement [Actions]]Toronto3 h

* Medicinal ingredients are based on automated analysis and should not be relied upon.

Return to top.

Canadian Intellectual Property